About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:2175792
Allelic
Composition
CrebbpGt(U-San)112Imeg/Crebbp+
Genetic
Background
involves: C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
CrebbpGt(U-San)112Imeg mutation (0 available); any Crebbp mutation (100 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• a subset of F2 heterozygous pups die within several days after birth

growth/size/body
• at 2-14 weeks, heterozygotes show a 30% reduction in body weight relative to wild-type mice
• however, heterozygotes gain weight at a rate that is comparable to that observed in wild-type mice
• in contrast to wild-type mice, heterozygotes fail to show a time-dependent increase in weight on a high-fat (HF) diet
• heterozygotes appear to be protected against HF diet-induced triglyceride accumulation in WAT
• heterozygotes exhibit significant intrauterine growth retardation in both weight and height relative to wild-type embryos

craniofacial
• at 19 dpc, heterozygotes exhibit a large anterior fontanel
• heterozygotes display widening of the frontal bone

skeleton
• at 19 dpc, heterozygotes exhibit a large anterior fontanel
• heterozygotes display widening of the frontal bone
• 1 of 30 heterozygotes display severe scoliosis
• heterozygotes exhibit delayed osseous maturation; notably, neither broad thumbs nor broad halluces are observed

cardiovascular system
• at 19.5 dpc, 9 of 54 heterozygous fetuses (16.6%) display non-overlapping cardiac abnormalities
• at 19.5 dpc, 1 of 54 heterozygous fetuses exhibit an atrial septal defect
• at 19.5 dpc, 7 of 54 heterozygous fetuses exhibit a ventricular septal defect of the membranous type

behavior/neurological
• heterozygotes display impaired long-term memory (LTM) in a step-through-type passive avoidance test and a cued fear-conditioning test
• in contrast, heterozygotes exhibit normal short-term memory in a Y-maze test as well as normal spatial learning in a water maze test
• hypolocomotion in a dark environment is noted throughout the entire 60 min observation period in the vertical activity, but only in the first 5 min in the horizontal activity
• heterozygotes display hypolocomotion in a dark environment but not in a light environment
• at least 2 of 54 heterozygotes display seizures

nervous system
N
• heterozygotes exhibit a normal brain morphology: despite the LTM deficit, neither sensorimotor nor gross neuroanatomical anomalies are observed
• at least 2 of 54 heterozygotes display seizures

limbs/digits/tail
• 1 of 30 heterozygotes exhibit oligodactyly

adipose tissue
• at 8 months, heterozygotes show a significant reduction in WAT weight per body weight; the weight of other tissues, including brown adipose tissue, remains unchanged
• reduced WAT mass is attributed to the inhibition of triglyceride accumulation in WAT
• at 8 months, heterozygotes fed a HC diet show a marked reduction in adipocyte size relative to similarly fed wild-type mice
• at death, heterozygotes fed a high-carbohydrate (HC) diet display a significantly reduced fat mass relative to similarly fed wild-type mice
• however, at P3, heterozygotes contain the same amount of BAT and WAT as wild-type mice

cellular
in vitro, embryonic fibroblasts from heterozygous mice exhibit a reduced ability to differentiate into adipocytes upon induction with conventional hormonal stimuli

homeostasis/metabolism
• in contrast to wild-type mice, heterozygotes fail to show a time-dependent increase in weight on a high-fat (HF) diet
• heterozygotes appear to be protected against HF diet-induced triglyceride accumulation in WAT
• heterozygotes show higher plasma insulin levels during glucose tolerance tests suggesting increased insulin secretion; however, this rise in insulin levels does not reach statistical significance
• heterozygotes fed a HF diet display increased serum leptin levels relative to the severely reduced WAT mass
• heterozygotes fed a HF diet display reduced serum levels of free fatty acids relative to wild-type mice
• heterozygotes exhibit a marked increase in resting oxygen consumption relative to wild-type mice
• in contrast, food intake remains relatively unchanged on either the HC or HF diet
• heterozygotes display increased glucose tolerance relative to wild-type mice on both a HC and a HF diet
• despite lipodystrophy, heterozygotes exhibit an enhanced glucose-lowering insulin effect relative to wild-type mice
• heterozygotes fed a HF diet show a significant increase in serum adiponectin levels, despite their markedly reduced WAT mass
• heterozygotes display changes in gene expression associated with decreased tissue triglyceride content in skeletal muscle and liver
• heterozygotes fed a HF diet display reduced Tnfa mRNA levels in WAT relative to wild-type mice
• heterozygotes fed a HF diet exhibit increased leptin sensitivity in response to exogenous leptin

immune system
• heterozygotes fed a HF diet display reduced Tnfa mRNA levels in WAT relative to wild-type mice

respiratory system

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
Rubinstein-Taybi syndrome DOID:1933 OMIM:180849
OMIM:610543
OMIM:613684
J:53370


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory